Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Viard

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|August 7, 2009
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patientsMarianne Burgard, Faroudy Boufassa, Jean-Paul Viard, et al.
AIDS (London, England)|March 3, 2006
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of timeJade Ghosn, Isabelle Pellegrin, Cécile Goujard, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
AIDS (London, England)|December 20, 2007
The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA studyColette J Smith, Christian H Olsen, Amanda Mocroft, et al.
AIDS (London, England)|September 9, 2004
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected menJade Ghosn, Marie-Laure Chaix, Gilles Peytavin, et al.
AIDS Patient Care and Stds|August 21, 2024
Sexual Health of Young Adults Living with Perinatally Acquired HIV in Paris, France: A Qualitative StudyNour Ibrahim, Jean-Paul Viard, Maude Ludot-Grégoire, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell countsLaurent Hocqueloux, Véronique Avettand-Fènoël, Sophie Jacquot, et al.
Plos One|September 24, 2013
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort studyCamille Legeai, Corinne Vigouroux, Jean-Claude Souberbielle, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretroviralsMinh P Lê, Linda Belarbi, Marie-Laure Chaix, et al.
The Journal of Infectious Diseases|June 15, 2004
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA studyUlrik Bak Dragsted, Amanda Mocroft, Stefano Vella, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|August 7, 2009
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patientsMarianne Burgard, Faroudy Boufassa, Jean-Paul Viard, et al.
AIDS (London, England)|March 3, 2006
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of timeJade Ghosn, Isabelle Pellegrin, Cécile Goujard, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
AIDS (London, England)|December 20, 2007
The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA studyColette J Smith, Christian H Olsen, Amanda Mocroft, et al.
AIDS (London, England)|September 9, 2004
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected menJade Ghosn, Marie-Laure Chaix, Gilles Peytavin, et al.
AIDS Patient Care and Stds|August 21, 2024
Sexual Health of Young Adults Living with Perinatally Acquired HIV in Paris, France: A Qualitative StudyNour Ibrahim, Jean-Paul Viard, Maude Ludot-Grégoire, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell countsLaurent Hocqueloux, Véronique Avettand-Fènoël, Sophie Jacquot, et al.
Plos One|September 24, 2013
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort studyCamille Legeai, Corinne Vigouroux, Jean-Claude Souberbielle, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretroviralsMinh P Lê, Linda Belarbi, Marie-Laure Chaix, et al.
The Journal of Infectious Diseases|June 15, 2004
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA studyUlrik Bak Dragsted, Amanda Mocroft, Stefano Vella, et al.
Pageof 14